|
Canada-0-CARTAGE 公司名錄
|
公司新聞:
- Stivarga: Uses, Dosage, Side Effects Warnings - Drugs. com
Stivarga is a cancer medicine that interferes with the growth and spread of cancer cells in the body Stivarga is used to treat colorectal cancer and liver cancer It is also used to treat a rare type of tumor that can affect the esophagus, stomach, or intestines Stivarga is usually given after other cancer medications have been tried without
- STIVARGA® (regorafenib) | Patient Website
STIVARGA* is a chemo-free oral option used in previously treated mCRC
- Stivarga - Chemocare
Stivarga ® can cause tiredness, weakness or blurred vision If you have any of these symptoms, use caution when driving a car, using machinery, or anything that requires you to be alert If you have any of these symptoms, use caution when driving a car, using machinery, or anything that requires you to be alert
- Stivarga: Cancer Treatment Uses, Side Effects Dosage
Stivarga is a chemotherapy drug used to treat colon or rectal cancer that has spread to other parts of the body, a rare stomach, bowel, or esophagus cancer called GIST (gastrointestinal stromal tumors), and a type of liver cancer called hepatocellular carcinoma (HCC)
- Regorafenib - Wikipedia
Regorafenib, sold under the brand name Stivarga among others, is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK) Regorafenib shows anti- angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition
- STIVARGA® (regorafenib) | Official HCP Website
Indications STIVARGA is indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type, an anti-EGFR therapy
- Regorafenib (Stivarga) | Cancer information - Cancer Research UK
Regorafenib Regorafenib is a targeted cancer drug You pronounce regorafenib as re-gor-af-e-nib It is also known as Stivarga You might have it as a treatment for: gastro intestinal stromal cancer (GIST) – a rare type of soft tissue sarcoma of the stomach or intestines
- Stivarga (Regorafenib Tablets): Side Effects, Uses, Dosage . . .
Uses for Stivarga Colorectal Cancer STIVARGA is indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type, an anti-EGFR therapy
- Frequently Asked Questions About Stivarga® - CancerConnect
Stivarga is used to treat patients with metastatic colorectal cancer that has previously been treated with certain types of chemotherapy and other medications Stivarga is also used for a rare cancer called a GIST (gastrointestinal stomach tumor) that cannot be treated with surgery or that has spread to other parts of the body and for which
- STIVARGA (regorafenib) Label - Food and Drug Administration
Stivarga is a kinase inhibitor indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy (1)
|
|